LD Micro Invitational
June 4th-5th, 2019
Luxe Hotel Sunset Boulevard (Bel Air, California)
The 9th annual LD Micro Invitational will feature company presentations from hundreds of select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit www.ldmicro.com
Safeguard Scientifics Inc. (SFE)
Safeguard Scientifics (NYSE: SFE) provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. Safeguard targets companies that are capitalizing on the next wave of enabling technologies with a particular focus on the Internet of Everything, enhanced security and predictive analytics. For more than 60 years, Safeguard has a distinguished track record of fostering innovation and building market leaders. For more information, visit the company's website at www.safeguard.com.
Stereotaxis Inc. (STXS)
Stereotaxisc (OTC: STXS) is a global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. The core components of Stereotaxis' systems have received regulatory clearance in the United States, European Union, Japan, Canada, China and elsewhere. For more information, visit the company's website at www.stereotaxis.com.
iConsumer Corp. (RWRDP)
iConsumer (OTC: RWRDP) is the next generation loyalty and rewards platform that helps its members understand and participate in the stock market. Consumers are rewarded with publicly traded equity - RWRDP - whenever they shop at 2,000 participating retailers. Retailers pay iConsumer for bringing those customers to them. iConsumer is heeding SEC Chairman Jay Clayton's April 2019 call for "companies to access the public capital markets earlier in their life cycle." Consumer is the early-stage company focused on giving ordinary people the experience of being a public company shareholder, simply because they shopped. For more information, visit the company's website at www.iConsumer.com.
Generation Next (VEND)
Generation Next (OTC: VEND) is positioning itself as a leader in Robotics + Automation + Vending technologies. The company delivers on-the-go solutions for consumers demanding on-the-go products, providing a point-of-sale experience like no other - fully-automated robotic vending solutions - and providing locations with a solid and consistent revenue opportunity. Generation NEXT is committed to the development and delivery of robotic vending technologies that will enhance customer experiences, satisfaction and provide innovative point-of-sale solutions across the food, beverage and photo industries around the world. For more information, visit the company's website at www.gennextbrands.com.
LiveXLive Media Inc. (LIVX)
LiveXLive Media (NASDAQ: LIVX) is a global digital media company focused on live entertainment. The company operates LiveXLive, one of the industry's leading live music streaming platforms; Slacker Radio, a streaming music pioneer; and produces original music-related content. LiveXLive is the first 'live social music network', delivering premium livestreams, digital audio and on-demand music experiences from the world's top music festivals and concerts, including Rock in Rio, EDC Las Vegas, Hangout Music Festival, and many more. Through its owned and operated Internet radio service, Slacker Radio, LiveXLive delivers users access to millions of songs and hundreds of expert-curated stations. For more information, visit the company's website at www.livexlive.com.
NXT Energy Solutions Inc. (NSFDF)
NXT Energy Solutions (OTC: NSFDF) offers a unique geophysical service to the upstream oil and gas industry using its proprietary gravity-based Stress Field Detection (SFD) remote-sensing survey system. SFD is used to rapidly identify and rank prospect- level leads to aid clients in focusing their exploration efforts. Currently, SFD is the only airborne tool that provides information on areas conducive to fluid entrapment in the sedimentary column. The SFD survey is complementary to existing geophysical methods, particularly seismic programs. In pre-seismic applications, SFD can generate high-potential prospect leads in large underexplored areas. In post-seismic applications, SFD can prioritize seismic prospects based on their reservoir potentials. For more information, visit the company's website at www.nxtenergy.com.
Thunderbird Entertainment Group (TSX-V: TBRD)
Thunderbird Entertainment Group (TSX-V: TBRD) is a multi-platform media production, distribution and rights management company headquartered in Vancouver, Canada. Thunderbird's award-winning programs cover multiple genres with a significant focus on kids and family entertainment, scripted comedy, drama and factual/non-scripted content. Thunderbird's projects include Highway Thru Hell for Discovery, Oscar winning Blade Runner 2049, CSA winning Kim's Convenience for CBC and Netflix, and the animated Emmy winning series Beat Bugs for Netflix. Additionally, Thunderbird's animation company, Atomic Cartoons is producing Last Kids on Earth based on the New York Times best-selling book series for Netflix and is in development on Eerie Elementary and Princesses Wear Pants. For more information, visit the company's website at www.thunderbird.tv.
Paysign Inc. (PAYS)
Paysign (NASDAQ: PAYS) is an experienced prepaid debit card payment solutions provider and integrated payment processor with over 2.5 million cardholders in its portfolio. Paysign designs and develops payment solutions, prepaid card programs, and customized payment services for consumer, corporate and public sector applications. Paysign's corporate incentive prepaid cards are changing the way corporations reward, motivate, and engage their current and potential customers, employees, and agents. Paysign's customizable solutions offer significant cost savings while improving brand recognition and customer loyalty. For more information, visit the company's website at www.paysign.com.
Todos Medical (TOMDF)
Todos Medical (OTC: TOMDF) is a cancer in-vitro-diagnostic company engaging in the development of a series of blood tests for the early detection of a variety of cancers. The company has developed two cancer screening tests based on TBIA (Todos Biochemical Infrared Analyses), a method for cancer screening using peripheral blood analysis. The TBIA screening method is based on the cancer's influence on the immune system which triggers biochemical changes in peripheral blood mononuclear cells and plasma. This proprietary and patented method incorporates biochemistry, physics and signal processing. The company's two cancer screening tests, TM-B1 and TM-B2 are CE marked in the EU. For more information, visit the company's website at www.todosmedical.com.
NervGen (OTC: NGENF) is creating innovative solutions for the treatment of nerve damage, including spinal cord injuries and peripheral nerve injuries. The company also continues to research secondary applications such as multiple sclerosis, stroke, acute myocardial infarction induced arrhythmia and other neurodegenerative diseases. NervGen plans to initiate a phase 1 human clinical trial for its lead compound, NVG-291, in early 2020 under an Investigational New Drug application with the FDA. NervGen is advancing NVG-291 for the treatment of spinal cord injury as the company believes this indication is a large unmet need and significant business opportunity. For more information, visit the company's website at www.nervgen.com.
RIWI Corp. (CSE: RIWI) (RWCRF)
RIWI Corp. (CSE: RIWI) (OTC: RWCRF) is a global trend-tracking and prediction technology firm. On a monthly or annual subscription basis, RIWI offers its clients tracking surveys, continuous risk monitoring, predictive analytics and ad effectiveness tests in all countries. For more information, visit the company's website at www.riwi.com.
Nephros Inc. (NEPH)
Nephros (OTC: NEPH) is a commercial-stage medical device company that develops and sells high performance liquid purification filters, as well as a hemodiafiltration system for the treatment of patients with End Stage Renal Disease. Nephros filters or ultrafilters are used by dialysis centers for assisting in the added removal of biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and the patients. Additionally, Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (i.e. Legionella, Pseudomonas), virus and endotoxin from water. These ultrafilters provide barriers that assist in improving infection control with showers, sinks, and ice machines. For more information, visit the company's website at www.nephros.com.
Pulse Evolution Group Inc. (DGLF)
Pulse Evolution Group (DGLF), including its consolidated subsidiaries, is a globally recognized, market leading developer of hyper-realistic digital humans – computer generated assets that can be distributed across the full spectrum of traditional media and emerging display technologies, including live entertainment, virtual reality, augmented reality, mobile, interactive and artificial intelligence applications. In August 2018, the company acquired Evolution AI Corporation, a developer of digital humans as an 'inter-Face' of artificial intelligence applications, including its majority interest in Pulse Evolution Corporation, a globally recognized leader in the development of hyper-realistic digital humans for entertainment. For more information, visit the company's website at www.pulseevolution.com.
Tinybeans Group Ltd. (TNYYF)
Tinybeans Group (TNYYF) owns and operates Tinybeans, a photo journal app that allows parents to organize their children's memories, milestones, and growth. TNY's mission is to create happy memories for every family by providing a platform to track their child's growth and development, at the same time creating a safe and secure social platform where they can share their photos with friends and family. For more information, visit the company's website at www.tinybeans.com.
LifeVantage Corp. (LFVN)
LifeVantage (NASDAQ: LFVN) is a pioneer in Nutrigenomics - a science dedicated to biohacking the human aging code. The company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including Protandim, a line of scientifically-validated dietary supplements; TrueScience, a line of Nrf2 infused skin care and hair care products; Petandim for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs; Axio Smart Energy Drink mixes; PhysIQ, a Smart Weight Management System; and Omega+, a 3-in-1 fish oil supplement. For more information, visit the company's website at www.lifevantage.com.
Excelsior Mining Corp. (EXMGF)
Excelsior Mining (OTC: EXMGF) is a mineral exploration and development company that is advancing the Gunnison Copper Project in Cochise County, Arizona. The project is an advanced staged, low cost, environmentally friendly in-situ recovery copper extraction project that is fully-permitted to 125 million pounds per year of copper cathode production. The Feasibility Study projected an after-tax NPV of US$ 807 million and an IRR of 40% using a US$ 2.75 per pound copper price and a 7.5% discount rate. For more information, visit the company's website at www.excelsiormining.com.
Aehr Test Systems (AEHR)
Aehr Test Systems (NASDAQ: AEHR) is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has over 2,500 systems installed worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader. For more information, visit the company's website at www.aehr.com.
Lantronix Inc. (LTRX)
Lantronix (NASDAQ: LTRX) is a global provider of secure data access and management solutions for the Internet of Things (IoT) assets. The company mission is to be the leading supplier of IoT solutions that enable companies to dramatically simplify the creation, deployment, and management of IoT projects. Lantronix is an innovator in enabling customers to build new business models and realize the possibilities of the Internet of Things. Lantronix's connectivity solutions are deployed inside millions of machines serving a wide range of industries, including industrial, medical, security, transportation, retail, financial, environmental and government. For more information, visit the company's website at www.lantronix.com.
Dunnedin Ventures (TSX-V: DVI)
Dunnedin Ventures (TSX-V: DVI) is advancing its wholly owned copper porphyry projects in British Columbia and Arizona; and the Kahuna diamond project in Nunavut. Dunnedin holds the Trapper porphyry project in the northern Golden Triangle region of British Columbia, the MPD project in south-central British Columbia near Princeton and the Mohave copper-molybdenum-silver porphyry project in Mohave County, Arizona, USA. All three projects have been historically drilled and are interpreted to overlie copper porphyry systems having surface geochemical, geophysical and regional alteration signatures of considerable size. The Kahuna diamond project hosts a high-grade, near surface inferred diamond resource and numerous kimberlite targets. For more information, visit the company's website at www.dunnedinventures.com.
OncoSec Medical Inc. (ONCS)
OncoSec Medical (NASDAQ: ONCS) is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead immunotherapy platform, TAVO, enables the intratumoral delivery of DNA-based interleukin-12 (IL-12), a naturally occurring protein with immune-stimulating functions. Results from recently completed clinical studies of TAVO have demonstrated a local immune response, and subsequently, a systemic effect as either a monotherapy or combination treatment approach. In addition to TAVO, OncoSec is identifying and developing new DNA-encoded therapeutic candidates and tumor indications for use with its ImmunoPulse platform. For more information, visit the company's website at www.oncosec.com.
Orion Energy Systems Inc. (OESX)
Orion Energy Systems (NASDAQ: OESX) is a provider of enterprise-grade LED lighting and energy project solutions. Orion manufactures and markets connected lighting systems encompassing LED solid-state lighting and smart controls. Orion systems incorporate patented design elements that deliver significant energy, efficiency, optical and thermal performance that drive financial, environmental, and work-space benefits for a wide variety of customers, including nearly 40% of the Fortune 500. For more information, visit the company's website at www.orionlighting.com.
AfterMaster Inc. (AFTM)
AfterMaster (OTC: AFTM) is an award-winning, leading edge audio technology company that specializes in the development of proprietary and groundbreaking audio technologies and products. Aftermaster Audio Labs developed Aftermaster audio, the first true breakthrough in audio technology that brings unparalleled amplitude, depth, clarity and fullness to any audio recording throughout its entire frequency range, without compromise. The Aftermaster team's discography includes more hit records than any other audio technology company in the world. For more information, visit the company's website at www.aftermaster.com.
Bion Environmental Technologies (BNET)
Bion Environmental Technologies (OTC: BNET) provides comprehensive treatment and resource recovery for animal waste from large-scale livestock production facilities. The technology platform achieves dramatic verified reductions in environmental impacts, including nutrients (nitrogen and phosphorus), ammonia, greenhouse and other gases, as well as pathogens in the waste stream, while improving resource and operational efficiencies through the production of valuable coproducts. For more information, visit the company's website at www.biontech.com.
PDS Biotechnology Corp. (PDSB)
PDS Biotechnology (NASDAQ: PDSB) has a growing pipeline of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, cervical cancer, anal cancer, prostate cancer, breast cancer and other cancers. PDS Biotechnology's lead product candidate PDS0101 demonstrated strong induction of the expected immune responses (e.g. antigen-specific CD8+ T-cell responses) without any observed dose-limiting toxicities in a completed phase 1/2a clinical trial. For more information, visit the company's website at www.pdsbiotech.com.
NaturalShrimp Inc. (SHMP)
NaturalShrimp (OTC: SHMP) is a global shrimp farming company that has developed a technology to produce fresh, gourmet-grade shrimp reliably and economically in an indoor, re-circulating, saltwater facility. The company's eco-friendly, bio-secure design does not rely on ocean water. It recreates the natural ocean environment allowing for high-density production which can be replicated anywhere in the world. For more information, visit the company's website at www.naturalshrimp.com.
RA Medical Systems Inc. (RMED)
RA Medical Systems (NYSE: RMED) commercializes excimer lasers and catheters for the treatment of dermatological and vascular diseases. In May 2017, DABRA laser system and disposable DABRA catheter received FDA 510(k) clearance in the U.S. for the intended use of ablating a channel in occlusive peripheral vascular disease. Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. DABRA and Pharos are both based on RaMedical's core excimer laser technology platform and deploy similar mechanisms of action. For more information, visit the company's website at www.ramed.com.
Cinedigm Corp. (CIDM)
Cinedigm (NASDAQ: CIDM) powers custom content solutions to the world's largest retail, media and technology companies. The company provides premium feature films and series to digital platforms including iTunes, Netflix, and Amazon, cable and satellite providers including Comcast, Dish Network and DirecTV, and major retailers including Walmart and Target. Leveraging Cinedigm's unique capabilities, content and technology, the company has emerged as a leader in the fast-growing over-the-top (OTT) channel business, currently with nine channels under management that reach hundreds of millions of devices, while also providing premium content and service expertise to the entire OTT ecosystem. For more information, visit the company's website at www.cinedigm.com.
NeuBase Therapeutics Inc.
NeuBase Therapeutics is developing its modular peptide-nucleic acid antisense oligonucleotide (PATrOL™) platform to address genetic diseases caused by mutant proteins with a single, cohesive approach. The systemically-deliverable PATrOL therapies have the potential to improve upon current gene silencing treatments by combining the advantages of synthetic approaches with the precision of antisense technologies. NeuBase intends to use its platform to address repeat expansion disorders, with an initial focus on Huntington's disease and myotonic dystrophy, as well as a variety other genetic disorders. As announced in January 2019, NeuBase has entered a definitive merger agreement with Ohr Pharmaceutical Inc. ("Ohr") (NASDAQ: OHRP). Upon closing of the transaction, the combined company will change its name to "NeuBase Therapeutics, Inc." and propose its trading symbol on the NASDAQ be changed to "NBSE." For more information, visit the company's website at www.neubasetherapeutics.com.
TIMIA Capital (TSX-V: TCA)
TIMIA Capital (TSX-V: TCAV) is a specialty finance company that provides growth capital to technology companies in exchange for payments based on monthly revenue. This alternative financing option complements both debt and equity financing, while allowing entrepreneurs and existing stakeholders to retain ownership and control of their business. TIMIA's singular focus is the fast growing, global, business-to-business Software-as-a-Service (or SaaS) segment. The company aligns with entrepreneurial management teams growing their sales from $1 Million to $10 Million in Annual Recurring Revenue. TIMIA continues to build the value and size of its portfolio by making new investments and follow-on investments in existing portfolio companies. For more information, visit the company's website at www.timiacapital.com.
RMS Medical Products (REPR)
RMS Medical Products (OTC: REPR) develops, manufactures and commercializes medical products used for home infusions. The FREEDOM Syringe Infusion System currently includes the FREEDOM60 and FreedomEdge Syringe Infusion Drivers, RMS Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. For more information, visit the company's website at www.rmsmedicalproducts.com.
Williams Industrial Services Group (WLMS)
Williams Industrial Services Group (OTC: WLMS) has been safely helping plant owners and operators enhance asset value for more than 50 years. The company provides a broad range of construction, maintenance and support services to customers in energy, power and industrial end markets. Williams' mission is to be the preferred provider of construction, maintenance, and specialty services through commitment to superior safety performance, focus on innovation, and dedication to delivering unsurpassed value to its customers. For more information, visit the company's website at www.wisgrp.com.
OZOP Surgical Corp. (OZSC)
OZOP Surgical (OTC: OZSC) invents, designs, develops, manufactures and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. The company's focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers. For more information, visit the company's website at www.ozopsurgical.com.
INmune Bio Inc. (INMB)
INmune Bio (NASDAQ: INMB) is a clinical-stage biotechnology company developing therapies targeting the innate immune system in cancer. INmune Bio is developing two products platforms that reengineer the patient's innate immune system's response to their cancer, INKmune and INB03. INKmune is a Natural Killer (NK) cell therapeutic that primes the patient's NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells (MDSC), which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio's product platforms target residual disease and utilize a precision medicine approach for treatment of a wide variety of hematologic malignancies and solid tumors. For more information, visit the company's website at www.inmunebio.com.
Genius Brands International Inc. (GNUS)
Genius Brands International (NASDAQ: GNUS) is a global kids media company developing, producing, marketing and licensing branded children's entertainment properties and consumer products for media and retail distribution. The company's "content with a purpose" brand portfolio includes preschool properties Rainbow Rangers for Nick Jr. and Llama Llama for Netflix; award-winning toddler brand, Baby Genius; adventure comedy STEM series, Thomas Edison's Secret Lab; and financial literacy and entrepreneurship series, Warren Buffett's Secret Millionaires Club. Genius Brands also launched the Genius Brands Network – comprised of Kid Genius Cartoon Channel and Baby Genius TV. The Network channels are available in approximately 80 million U.S. households via a variety of distribution platforms. For more information, visit the company's website at www.gnusbrands.com.
Aspen Group Inc. (ASPU)
Aspen Group (NASDAQ: ASPU) is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. For more information, visit the company's website at www.aspu.com.
Taoping Inc. (TAOP)
Taoping (NASDAQ: TAOP) is a leading provider of internet-based ad distribution and display terminal sharing systems and online retail platform in China. The company provides the integrated end-to-end digital advertising solutions enabling customers to distribute and manage ads on the ad display terminals. Connecting cloud-based ad terminal owners, advertisers and consumers, it builds up a resource sharing "Smart IoT Terminal - Taoping Net/ App – Taoping E-store" media ecosystem to ultimately achieve the mission to make advertising and branding affordable and effective for everyone. For more information, visit the company's website at www.taop.com.
BioCorRx Inc. (BICX)
BioCorRx (OTC: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components, first is an outpatient implant procedure that delivers naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component is a Cognitive Behavioral Therapy (CBT) program tailored specifically for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The company also conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals. For more information, visit the company's website at www.BioCorRx.com.
Blackboxstocks, Inc. (BLBX)
Blackboxstocks (OTC: BLBX) develops real-time, web and mobile based analytical software tools for day traders and swing traders. The company's servers, located near the NYSE, AMEX, NASDAQ, and OTC exchanges, drive its proprietary algorithms at near light speed. This allows the system to monitor and analyze over 13,000 stocks simultaneously. The platform employs predictive technology enhanced by artificial intelligence to find unusual market activity that can result in the rapid change in a stock's price. The complexity of its backend analytics are neatly hidden from the end user by a simple and easy to use interface/dashboard. The technology is currently under development and in the beta testing phase. For more information, visit the company's website at www.blackboxstocks.com.
ShiftPixy Inc. (PIXY)
ShiftPixy (NASDAQ: PIXY) is a disruptive human capital management platform, revolutionizing employment in the Gig Economy by delivering a next-gen mobile engagement technology to help businesses with shift-based employees navigate regulatory mandates, minimize administrative burdens and better connect with a ready-for-hire workforce. With expertise rooted in management's nearly 25 years of workers' compensation and compliance programs experience, ShiftPixy adds a needed layer for addressing compliance and continued demands for equitable employment practices in the growing Gig Economy. For more information, visit the company's website at www.shiftpixy.com.
VolitionRx Limited (VNRX)
VolitionRx Limited (NYSE: VNRX) is a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers. The tests are based on the technology platform of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition's products aim to help to diagnose a range of cancers quickly, simply, accurately and cost effectively. Volition intends to expand the application of its technology beyond cancer by exploring other disease applications. For more information, visit the company's website at www.volitionrx.com.
DPW Holdings Inc. (DPW)
DPW Holdings (NYSE: DPW) is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly owned subsidiaries and strategic investments, the company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. For more information, visit the company's website at www.DPWHoldings.com.
Upper Street Marketing Inc. (UPPR)
Upper Street Marketing (OTC: UPPR) is one of the only companies in the world to control every phase of the cannabidiol (CBD) extraction cycle from seed to consumer. With one of the only integrated "seed to consumer" platforms for participating in all phases of the industry from crop to value-added commercial and clinical product development, UPPR intends to be a leader in FDA cGMP (Current Good Manufacturing Practice) capabilities in the hemp and CBD marketplace. For more information, visit the company's website at www.upperstreetmarketing.com.
LandStar Inc. (LDSR)
LandStar (OTC: LDSR), through its wholly owned subsidiary DATA443 Risk Mitigation Inc., provides SaaS-based software solutions that secure data – across local devices, network, cloud, and databases – at rest and in flight. Its expanding suite of software products is highlighted by: (i) ArcMail (ii) ARALOC, a secure, cloud-based platform for the management, protection and distribution of digital content to desktop and mobile devices (iii) ClassiDocs, the Company's award-winning data classification and governance technology (iv) ClassiDocs for Blockchain (v) Data443 Privacy Manager (vi) Data443 virtual Data Protection Officer and (vii) the WordPress GDPR Framework. For more information, visit the company's website at www.data443.com.
Youngevity International Inc. (YGYI)
Youngevity International (NASDAQ: YGYI) is an omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution Coffee Company (now part of the company's food and beverage division). For more information, visit the company's website at www.YGYI.com.
Canntab Therapeutics (CSE: PILL) (CTABF)
Canntab Therapeutics (CSE: PILL) (OTC: CTABF) is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. For more information, visit the company's website at www.canntab.ca.
Ionix Technology Inc. (IINX)
Ionix Technology (OTC: IINX) is a holding company engaged in the photoelectric display and smart energy industries. The company has four operating subsidiaries: Changchun Fangguan Photoelectric Display Technology Co. Ltd; Shenzhen Baileqi Electronic Technology Co. Ltd; Lisite Science Technology (Shenzhen) Co. Ltd.; and Dalian Shizhe New Energy Technology Co. Ltd. Currently, IINX has embarked on the layout of industrialization and marketization of front end materials and back end modules of liquid crystal displays and applications of flexible folding display technology by taking Changchun Fangguan and Shenzhen Baileqi as production bases, to seize the market share of OLED high technology. For more information, visit the company's website at www.iinx-tech.com.
SenesTech Inc. (SNES)
SenesTech (NASDAQ: SNES) has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. SenesTech is changing the paradigm of pest management by targeting the root of the problem: reproduction. The company's product, ContraPest, can be purchased by licensed pest management professionals through national and regional distributors. For more information, visit the company's website at www.senestech.com.
Edison Nation Inc. (EDNT)
Edison Nation (NASDAQ: EDNT) is a vertically integrated innovation aggregation and full-service product development and manufacturing company, offering innovation sourcing, design, sales, fulfillment and shipping services. Edison Nation's model is to provide a risk mitigated platform that connects innovators with companies to bring new products to market. For more information, visit the company's website at www.edisonnation.com.
trutankless (OTC: TKLS) modernizes tankless water heating by promoting energy conservation and long-term savings with its revolutionary product for the benefit of homeowners, service professionals and consumers. Trutankless is engaged in manufacturing electric tankless water heaters that far surpasses traditional tank water heaters in energy efficiency, output, dependability and environmental sustainability. The company's patented products include WiFi capabilities to help modernize the water heating industry. The Trutankless brand mission is to apply smart engineering to forward-thinking technologies that save customers money, energy, and space. For more information, visit the company's website at www.trutanklessinc.com.
Nymox Pharmaceutical Corp. (NYMX)
Nymox Pharmaceutical (NYSE: NYMX) specializes in the research and development of therapeutics and diagnostics, with an emphasis on products targeted for the unmet needs of the rapidly aging male population in developed economies. The company's lead drug candidate for benign prostatic hyperplasia (BPH) Fexapotide Triflutate (FT) has completed phase 3 development in more than 70 clinical centers in the United States, involving more than 1700 patients during the entire clinical development program. The company will soon be filing for approval in major economies around the world, including the United States and Europe. In addition, the Company is developing Fexapotide for early-stage, non-aggressive prostate cancer (PCA). For more information, visit the company's website at www.nymox.com.
Relmada Therapeutics (RLMD)
Relmada Therapeutics (OTC: RLMD) is a clinical-stage biotechnology company developing novel medicines that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases. Relmada's lead program, dextromethadone (REL-1017), is an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor antagonists may have potential in the treatment of a range of psychiatric and neurological disorders associated with a variety of cognitive, neurological and behavioral symptoms. For more information, visit the company's website at www.relmada.com.
CURE Pharmaceutical Holding (CURR)
CURE Pharmaceutical Holding (OTC: CURR) is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm), one of the most advanced oral thin films on the market today. CURE is developing an array of products in innovative delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, and Israel. For more information, visit the company's website at www.curepharma.com.
SinglePoint Inc. (SING)
SinglePoint (OTC: SING) is a technology and investment vehicle focused on acquiring companies that will immediately benefit from the injection of technology integration and growth capital. Through acquisitions into horizontal markets, SinglePoint has been successful in building its portfolio by acquiring an interest in undervalued equities, thereby developing a rich, diversified portfolio base. The company holdings currently include mobile payments, ancillary cannabis products/services via SingleSeed, and blockchain solutions. For more information, visit the company's website at www.singlepoint.com.
Wize Pharma Inc. (WIZP)
Wize Pharma (OTC: WIZP) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including DES. Wize has in-licensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of DES, and other ophthalmological illnesses, including CCh and Sjögren's syndrome (Sjögren's). Wize's strategy involves engaging local or multinational distributors to handle the distribution of LO2A. Wize has finished a Phase II trial of LO2A for patients with CCH and is currently conducting a phase IV study for LO2A for DES in patients with Sjögren's. For more information, visit the company's website at www.wizepharma.com.
U.S. Nuclear Corp. (UCLE)
US Nuclear Corp (OTC: UCLE) is a radiation and chemical detection holding company specializing in the development and manufacturing and sales of radiation and chemical detection instrumentation. Through three operating divisions (Technical Associates (TA), Overhoff Technology (OTC), and Electronic Control Concepts (ECC), US Nuclear Corp. has more than 100 years of combined experience in supplying instrumentation to any industry utilizing radionuclides. This includes nuclear power plants, national laboratories, government agencies, homeland security, military, universities and schools, research companies, hospitals, medical and dental centers, energy companies, weapons facilities, first responders, local governments, and manufacturing plants. For more information, visit the company's website at www.usnuclearcorp.com.
Eastside Distilling Inc. (EAST)
Eastside Distilling (NASDAQ: EAST) has been producing high-quality, award-winning craft spirits since 2008. The company is distinguished by its highly decorated product lineup that includes Burnside Bourbon, West End American Whiskey, Goose Hollow Reserve, Below Deck Rums, Portland Potato Vodka, Hue-Hue Coffee Rum and a distinctive line of fruit infused spirits. Eastside Distilling is majority owner of Big Bottom and the Redneck Riviera Whiskey Co. All Eastside, Big Bottom and Redneck Riviera spirits are crafted from natural ingredients for quality and taste. Eastside's Mother Lode Bottling subsidiary is one of the Northwest's leading independent spirit bottlers and ready-to-drink canners. For more information, visit the company's website at www.eastsidedistilling.com.
CytoDyn Inc. (CYDY)
CytoDyn (OTC: CYDY) is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells. The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application in the first quarter of 2019 for that indication. For more information, visit the company's website at www.cytodyn.com.